Clark Tedford of LumiThera has received a $250,000 grant to treat macular degeneration from the Life Sciences Discovery Fund (LSDF). Part of LSDF’s $1.25 million Proof of Concept program, the grants are meant to accelerate the maturation of promising health-related technologies into commercial products. LumiThera’s project will focus on building a device that may delay the progression of dry age-related macular degeneration through the use of low-level laser therapy. “LSDF created the Proof of Concept granting program to nurture the vitality and competitiveness of Washington’s life sciences innovation community and help convert its ‘intellectual capital’ into tangible products,” said John DesRosier, LSDF executive director.